EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access

Associations of supramaximal resection with outcome in glioblastoma across age groups: A report of the RANO resect group

Nico Teske iD, Antonio Dono iD, Jacob S Young, Stephanie T Jünger, Gilbert Youssef, Levin Häni, Tommaso Sciortino, Francesco Bruno iD, Jorg Dietrich iD, Christine Y Mau, Michael Weller iD, Juergen Beck und 18 weitere

Neuro-Oncology · 01.02.2026 · 28 (2) · 470-484

DOI: 10.1093/neuonc/noaf239 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Neuro-Oncology, online erschienen am 25.10.2025. Verfasst von Nico Teske und 29 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Uniklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany (N.T., O.S., P.K.). Hauptthemen laut MEDLINE: Glioblastoma, Brain Neoplasms, Neoplasm Recurrence, Local, Neurosurgical Procedures. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The oncological role of resection in elderly patients with glioblastoma remains controversial. We evaluated the value of resection in patients ≥65 years with (1) newly diagnosed and (2) recurrent glioblastoma by comparing the prognostic relevance of extent of resection to patients <65 years.

Methods

The international RANO resect group retrospectively collected patients with newly diagnosed and recurrent IDH-wildtype glioblastoma from ten neuro-oncological centers. Associations of residual tumor with molecular and clinical markers and survival were analyzed.

Results

A total of 1260 patients with newly diagnosed glioblastoma were identified, including 512 patients ≥65 years. Lower postoperative contrast-enhancing tumor volumes were favorably associated with survival on uni- and multivariate analyses; however, the associations with outcome were more pronounced in younger patients. Only in patients <65 years, supramaximal resection was associated with more favorable survival (40 vs 20 months, P = .001). In 310 patients with first recurrence (≥65 years: 92), maximal resection of contrast-enhancing tumor was associated with favorable outcomes, particularly in younger patients. Neither older nor younger patients had favorable outcome associations of supramaximal resection in the recurrent setting. All findings were confirmed in propensity-score-matched analyses to minimize confounding effects of inherent differences in demographic and clinical markers (including second-line treatments) between older and younger patients.

Conclusions

While complete contrast-enhancing tumor resection is prognostic for favorable outcomes in older patients, associations of supramaximal resection with improved outcomes were only retained in younger patients with newly diagnosed disease. Those findings support stratified surgical approaches.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaBrain NeoplasmsNeoplasm Recurrence, LocalNeurosurgical ProceduresHumansAgedMaleFemaleMiddle AgedRetrospective StudiesAdultPrognosisAge FactorsAged, 80 and overSurvival RateFollow-Up StudiesYoung AdultTreatment Outcome

Stichwörter der Autor:innen

extent of resectionglioblastomaoutcomepatient stratificationsurgery

Autor:innen und Institutionen

  • Department of Neurosurgery, Uniklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany (N.T., O.S., P.K.).
  • Department of Neurosurgery, LMU University Hospital of the Ludwig-Maximilians-University Munich, Munich, Germany (N.T., J.-C.T., P.K.).
  • -German Cancer Consortium (DKTK), Partner Site, Munich, -Germany (N.T., J.-C.T., P.K.).
  • Department of Neurosurgery, McGovern Medical School at UT Health Houston, Houston, Texas, USA.
  • Department of Neurosurgery and Division of Neuro-Oncology, University of San Francisco, San Francisco, California, USA.
  • Department of Neurosurgery, University of Cologne, Cologne, Germany.

ORCID-Profile: Nico Teske, Antonio Dono, Francesco Bruno, Jorg Dietrich, Michael Weller, Shawn Hervey-Jumper, Susan M Chang, Maximilian I Ruge, Daniel P Cahill, Roberta Rudà, Patrick Y Wen, Nitin Tandon, Yoshua Esquenazi, Philipp Karschnia

Förderung

  • NCI NIH HHS

Zitieren

APA

Teske, N., Dono, A., Young, J. S., Jünger, S. T., Youssef, G., Häni, L., Sciortino, T., Bruno, F., Dietrich, J., Mau, C. Y., Weller, M., Beck, J., Hervey-Jumper, S., Molinaro, A. M., Chang, S. M., van den Bent, M., Vogelbaum, M. A., Ruge, M. I., Cahill, D. P., …, & Karschnia, P. (2026). Associations of supramaximal resection with outcome in glioblastoma across age groups: A report of the RANO resect group. Neuro-Oncology, 28(2), 470-484. https://doi.org/10.1093/neuonc/noaf239

Vancouver

Teske N, Dono A, Young JS, Jünger ST, Youssef G, Häni L, et al. Associations of supramaximal resection with outcome in glioblastoma across age groups: A report of the RANO resect group. Neuro-Oncology. 2026;28(2):470-484. doi:10.1093/neuonc/noaf239

BibTeX
@article{Teske2026,
  author = {Teske, Nico and Dono, Antonio and Young, Jacob S and Jünger, Stephanie T and Youssef, Gilbert and Häni, Levin and Sciortino, Tommaso and Bruno, Francesco and Dietrich, Jorg and Mau, Christine Y and Weller, Michael and Beck, Juergen and Hervey-Jumper, Shawn and Molinaro, Annette M and Chang, Susan M and van den Bent, Martin and Vogelbaum, Michael A and Ruge, Maximilian I and Cahill, Daniel P and Rudà, Roberta and Bello, Lorenzo and Grau, Stefan J and Schnell, Oliver and Huang, Raymond Y and Wen, Patrick Y and Tandon, Nitin and Berger, Mitchel S and Tonn, Joerg-Christian and Esquenazi, Yoshua and Karschnia, Philipp},
  title = {Associations of supramaximal resection with outcome in glioblastoma across age groups: A report of the RANO resect group},
  journal = {Neuro-Oncology},
  year = {2026},
  volume = {28},
  number = {2},
  pages = {470--484},
  doi = {10.1093/neuonc/noaf239}
}
Kostenlos starten →